Windlas Biotech Limited Price (WINDLAS.NS)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

20,872,745

(3.5274)%

Windlas Performance History

Community Sentiment 0 votes
↑ 0% ↓ 0%

Description

Windlas Biotech Limited operates as a contract development and manufacturing organization (CDMO). Its CDMO services include product discovery, product development, licensing, and commercial manufacturing generic products, including generic products. The company provides its CMDO products and services across a range of pharmaceutical and nutraceutical conventional, and novel products for customers who market such products under their own brand names to the end users. It also offers manufactures various domestic trade generics and over-the-counter brand pr... Read More

Sector: Healthcare

  • Previous Close Fetching Data...
  • Range $495.65-1198.25
  • Market Cap 19.37B
  • Enterprise Value No Data
  • Avg Volume Fetching Data...
  • P/E Ratio Fetching Data...
  • Dividend Yield Fetching Data...

Industry: Drug Manufacturers - Specialty & Generic

  • ceo: Ms. Komal Gupta
  • IPO Date: August, 16, 2021
  • Country: IN
  • Currency: INR
  • Headquaters: No Data
  • Employees: 1154

- Revenue from each product or segment:

Product or Segment Value: % - Total Last 3Y:
news-img

- Revenue by Region

Product or Segment Value: % - Total Last 3Y:
news-img
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation